BPC
ALAB icon

Bryce Point Capital’s Astera Labs ALAB Stock Holding History

Bryce Point Capital’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$610K Buy
+3,117
New +$513K 0.74% 35

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Bryce Point Capital's ALAB Position: Q3 2025 in Review

Bryce Point Capital opened a new position in Astera Labs (ALAB) in Q3 2025: 3,117 shares worth $610K. The stake represents 0.74% of the portfolio and ranks #35 among its holdings.

657 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

  • Bryce Point Capital held 3,117 shares of Astera Labs worth $610K as of Q3 2025.
  • Astera Labs was a new Bryce Point Capital position in Q3 2025.
  • Astera Labs made up 0.74% of Bryce Point Capital's portfolio in Q3 2025, its #35 holding.
  • 657 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on Bryce Point Capital's 13F filing for Q3 2025, filed 6 Nov 2025.